JILLIAN SINCLAIR: Open Payments
NPI 1437638848 · DANVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$94 in 6 payments from 4 companies in 2025. Trend: 2023 $1,609 · 2024 $258 · 2025 $94
Food & beverage: $94
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Ardelyx, Inc. | 2 | $27 |
| QOL Medical, LLC | 1 | $19 |
| ABBVIE INC. | 1 | $14 |
Products named: IBSRELA, Sucraid, EOHILIA, ENTYVIO, LINZESS.
Industry payments across IN — which companies pay providers there.
